RPRX earnings date and history (2026)
Royalty Pharma plc (RPRX) next reports earnings on Wed Nov 4. Analysts expect EPS of $1.18 (4 estimates), against $1.17 in the same quarter a year ago. Last time, on Wed Aug 5, it reported $1.32 against a $1.27 consensus (+3.9%). Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Newest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s session is known.
| Date | Est | Actual | Move |
|---|---|---|---|
| Aug 5, 2026 | $1.27 | $1.32 | — |
| May 6, 2026 | $1.22 | $1.30 | — |
| Feb 11, 2026 | $1.33 | $1.46 | — |
| Nov 5, 2025 | $1.11 | $1.17 | — |
About this data
Report dates, sessions, consensus EPS estimates, reported EPS and surprises come from Nasdaq's public earnings calendar and analyst pages, read daily; they are estimates, subject to change, and may not be accurate. A quarter the calendar saw is shown with its session; a quarter known only from the analyst page has none, and its move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- When does RPRX report earnings?
- RPRX is scheduled to report on Wed Nov 4, according to Nasdaq's earnings calendar. Dates are set by the company and can move.
- What EPS is expected from RPRX?
- The consensus estimate is $1.18 a share across 4 analysts; the same quarter a year ago came in at $1.17.
- Did RPRX beat earnings last quarter?
- Yes: on Wed Aug 5 RPRX reported $1.32 against a $1.27 consensus, a +3.9% surprise.
